Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications.
Gradilone
Angela
A
Pulcinelli
Fabio Maria
FM
Lotti
Lavinia Vittoria
LV
Martino
Simone
S
Mattiello
Teresa
T
Frati
Luigi
L
Aglianò
Anna Maria
AM
Gazzaniga
Paola
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068579:Celecoxib; D045744:Cell Line, Tumor; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000628:therapy; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000096:biosynthesis*; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D011720:Pyrazoles; D013449:Sulfonamides; C073492:ABCC4 protein, human